This study improves our understanding of the molecular mechanism of TAM-EVs in tumor angiogenesis and identifies the miR-21-5p/YAP1/HIF-1 axis as a potential therapeutic target for HNSCC. The gene discussed is HIF1A; the disease is neoplasm.